Russia: EpiVacCorona Vaccine

The EpiVacCorona vaccine is expected to provide year-long immunity to COVID-19, acting deputy head of the Vector State Research Centre Tatiana Nepomnyashchih stated on Thursday. She also noted that Vector has concluded vaccine trials for the 60+ age group, saying there were no acute adverse effects. “Read More!”

Soon another Russian Vaccine will be available!

Interesting tidbit…

I have had Sputnik V…

WtR

kKEETON @ Windows to Russia…

Permission to reprint in whole or in part is gladly granted, provided full credit is given...

Leave a Reply

Your email address will not be published. Required fields are marked *